Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Rheumatology
•
COVID-19
•
General Rheumatology
•
Infectious Disease
How do you counsel immunosuppressed patients regarding a third Covid vaccination dose if they have had 2 doses of mRNA vaccine and either pre or post vaccine Covid infection?
Related Questions
Would you advise an immunocompromised patient that developed a dermatomal rash after the first recombinant zoster vaccine to receive the second dose?
What is the optimal timing for Zoster vaccine administration for a patient who recently recovered from herpes zoster infection and is now planning to start B-cell depletion therapy?
What is your approach to RSV vaccination in immunocompromised patients?
How do you approach Covid vaccine counseling in patients with rheumatic disease and history of pericarditis/serositis?
What is your approach to a patient on immunosuppressants with an outpatient cutaneous MRSA infection or to a MRSA carrier?
In a patient who is on oral DMARDs and has received 3 COVID boosters, but recently had COVID-19 infection, is bivalent booster still recommended 3 months later?
How do you approach management of patients with active RA and recurrent non-severe C.diff?
What is your approach to working up diarrhea in an immunocompromised patient?
When is it safe to resume DMARDs in a patient who was diagnosed with active TB and started on treatment?
Do you have a preference between Quantiferon Gold and T-spot TB for screening in patients starting immunosuppressive agents?
